GlassScriptPhysician profile
Eugene Daniel Mahaney
NPI 1619978236
$17,126.90
in general payments reported to CMS, 2019-2025
58 companies · $1,408 in 2025
The $1,408 reported for 2025 was more than what 75% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,600 · 2020: $677 · 2021: $1,899 · 2022: $1,572 · 2023: $4,323 · 2024: $1,648 · 2025: $1,408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,452 · Travel and Lodging: $1,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,451.76 |
| Travel and Lodging | $1,926.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,920.14 | 2019-2025 | Superion Indirect Decompression System, Intracept, General - Pain Management |
| Medtronic, INC. | $2,015.91 | 2021-2025 | Synchromedii, Intellis Adaptivestim, Inceptiv |
| Abbvie INC. | $738.14 | 2021-2025 | |
| Relievant Medsystems, INC. | $618.20 | 2021-2023 | Intracept |
| Collegium Pharmaceutical, INC. | $602.83 | 2019-2025 | Xtampza, Belbuca |
| Allergan, INC. | $530.18 | 2019-2022 | |
| Tersera Therapeutics LLC | $425.54 | 2019-2025 | Prialt |
| Abbott Laboratories | $397.15 | 2019-2025 | Proclaim, Eterna |
| Scilex Pharmaceuticals INC. | $336.67 | 2019-2023 | Ztlido |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $331.18 | 2020-2025 | Relistor |
| Nevro Corp. | $326.61 | 2019-2024 | Senza |
| Vertos Medical, INC. | $302.67 | 2021-2024 | Mild Device Kit |
| Amgen INC. | $250.19 | 2019-2022 | |
| Pfizer INC. | $235.93 | 2019-2024 | |
| Medtronic USA, INC. | $233.85 | 2019-2020 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Mahaney listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.